Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q1 | -- | -- | -- | -$0.43 | -- |
| 03/02/2026 | Q4 | -- | -- | -- | -$0.41 | -- |
| 11/06/2025 | Q3 | -- | -- | -$0.43 | -$0.52 | $0.10 |
| 08/07/2025 | Q2 | -- | -- | -$0.71 | -$0.68 | -$0.03 |
| 05/08/2025 | Q1 | -- | -- | -$0.92 | -$0.75 | -$0.17 |
| 03/03/2025 | Q4 | -- | -- | -$0.82 | -$0.96 | $0.14 |
| 11/07/2024 | Q3 | $354.2K | -- | -$0.95 | -$0.98 | $0.03 |
| 08/07/2024 | Q2 | $399.6K | -- | -$0.92 | -$0.85 | -$0.07 |
| 05/06/2024 | Q1 | $387.1K | -- | -$0.78 | -$0.77 | -$0.01 |
| 02/27/2024 | Q4 | $458.3K | -- | -$0.69 | -$0.82 | $0.13 |
| 11/09/2023 | Q3 | -- | -- | -$0.70 | -$0.77 | $0.07 |
| 08/09/2023 | Q2 | -- | -- | -$0.70 | -$0.69 | -$0.01 |
| 05/09/2023 | Q1 | -- | -- | -$0.67 | -$0.67 | -- |
| 03/09/2023 | Q4 | -- | -- | -$0.72 | -$0.70 | -$0.02 |
| 11/08/2022 | Q3 | -- | -- | -$0.65 | -$0.74 | $0.09 |
| 08/08/2022 | Q2 | -- | -- | -$0.82 | -$0.81 | -$0.01 |
| 05/09/2022 | Q1 | -- | -- | -$0.78 | -$0.74 | -$0.04 |
| 02/28/2022 | Q4 | -- | -- | -$0.68 | -$0.75 | $0.07 |
| 11/09/2021 | Q3 | -- | -- | -$0.75 | -$0.69 | -$0.06 |
| 08/09/2021 | Q2 | -- | -- | -$0.64 | -$0.67 | $0.03 |
| 05/10/2021 | Q1 | -- | -- | -$0.64 | -$0.60 | -$0.04 |
| 03/16/2021 | Q4 | -- | -- | -$0.54 | -$0.60 | $0.06 |
| 11/10/2020 | Q3 | -- | -- | -$0.47 | -$0.60 | $0.13 |
| 08/11/2020 | Q2 | -- | -- | -$1.39 | -$0.68 | -$0.71 |
| 03/31/2020 | Q1 | -- | -- | -- | -- | -- |
| 12/31/2019 | Q4 | -- | -- | $1.75 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$0.67 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$0.77 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$0.70 | -- | -- |
Pliant Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
Pliant Therapeutics, Inc. announced earnings per share of -$0.43 which represents a beat of analyst forecast a -$0.52 per share.
Pliant Therapeutics, Inc. reported -$436K that represents -$0.01 per share over the last quarter.
Pliant Therapeutics, Inc.'s earnings are forecast to decrease from -$3.47 per share to -$2.45 per share next year representing a decrease of -29.57%.
Pliant Therapeutics, Inc.'s next earnings date is March 2, 2026.
Signup to receive the latest stock alerts
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $3.9T
P/E Ratio: 36x
Market Cap: $3.8T
P/E Ratio: 39x
Regencell Bioscience Holdings Ltd. [RGC] is up 22.74% over the past day.
Innodata, Inc. [INOD] is up 4.84% over the past day.
AeroVironment, Inc. [AVAV] is up 6.62% over the past day.